Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies

Frontiers in Cellular and Infection Microbiology(2021)10.3389/fcimb.2021.673100Source: DataRank Database

Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies is a research paper published in Frontiers in Cellular and Infection Microbiology (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (26)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Anou M. Somboro ORCID,Seydou Diabaté ORCID,Bacar Baya,A. Koné ORCID,Yéya dit Sadio Sarro ORCID

Live enrichment

PubMed:34950603 PMC:PMC8688706

FIC NIH HHS

Grant: D43 TW010350

NIAID NIH HHS

Grant: R21 AI148033

FIC NIH HHS

Grant: D43 TW010543

National Institutes of Health

Grant: 3D43TW010543-06S3

Partnership for Global Health Research Training Program(Renewal)

National Institutes of Health

Grant: 5R21AI148033-02

Metabolic and Immune Consequences of Antibiotic-Related Microbiome Alterations during TB Treatment

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2021.673100/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2021.673100/full

repositoryhttps://doaj.org/article/1f7ae8a2fbf1460e929b0dd3d16a3f2e

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8688706

Europe_PMChttps://europepmc.org/articles/PMC8688706

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansHIV InfectionsPharmaceutical PreparationsAntitubercular AgentsProbioticsMicrobiotaDysbiosisGastrointestinal Microbiome

Keywords

TuberculosisGut MicrobiotaDysbiosisTb TreatmentHost Directed-therapiesMicrobiotaProbioticsAntitubercular AgentsHIV InfectionsMicrobiologyQR1-502Gastrointestinal MicrobiomeCellular and Infection MicrobiologyPharmaceutical PreparationsHumans

Sustainable Development Goals

SDG 3: 3. Good health